Stocks and Finance

Arena Pharmaceuticals

Arena Pharmaceuticals 5/22/2012

09:12 : Arena Pharmaceuticals (ARNA) +4.7% to $6.24 after it yesterday completed ... - Arena Pharmaceuticals (ARNA) +4.7% to $6.24 after it yesterday completed its secondary public offering and underwriters fully exercised their option to purchase additional stock. Arena sold almost 12.65M shares at $5.50 each, ...
Source : seekingalpha-com

Arena Pharmaceuticals 5/9/2012

10:37 : Arena Pharmaceuticals, Blue Nile Among Stocks Gapping Up Wednesday - Today, these stocks gapped up with opening prices significantly higher than the close on the previous trading day: Arena Pharmaceuticals (NASDAQ:ARNA) closed the previous trading session at $3.42, gapping up to open at $3.79 ...
Source : foxbusiness-com

Arena Pharmaceuticals 5/8/2012

12:11 : Cognizant Technology, Arena Pharmaceuticals Included in Stocks Up on High ... - A few stocks are up on high volume today: Cognizant Technology (NASDAQ:CTSH) is up on high volume today, trading with volume of 8.6 million, or 1.5 times its average daily volume.
Source : foxbusiness-com

Arena Pharmaceuticals 5/2/2012

10:26 : Arena Pharmaceuticals leaps on diet drug news - LOS ANGELES (MarketWatch) -- Shares of Arena Pharmaceuticals leaped Wednesday after the company announced the U.S. Food & Drug Administration will hold a hearing May 10 to discuss the application of the company's anti-obesity ...
Source : marketwatch-com

Arena Pharmaceuticals 3/30/2012

14:22 : Vivus ([[VVUS]] +5.3%) and Arena Pharmaceuticals ([[ARNA]] +0.3%), competi - Vivus (VVUS +5.3%) and Arena Pharmaceuticals (ARNA +0.3%), competing to win U.S. regulatory approval for weight-loss treatments, probably won't be affected by an FDA advisory panel's recommendation for heart-risk ...
Source : seekingalpha-com

Arena Pharmaceuticals 2/2/2012

14:00 : Arena Pharmaceuticals ([[ARNA]] -3.6%) says an FDA advisory committee ... - Arena Pharmaceuticals (ARNA -3.6%) says an FDA advisory committee will meet in the second quarter to discuss the company's resubmitted application for its weight-loss drug lorcaserin. There are concerns by many analysts that ...
Source : seekingalpha-com

Arena Pharmaceuticals 1/30/2012

09:10 : Arena Pharmaceuticals (ARNA) moves up 6.5% premarket after traders line ... - Arena Pharmaceuticals (ARNA) moves up 6.5% premarket after traders line up the biopharmaceutical company as a juicy candidate for a takeover bid. Post your comment!
Source : seekingalpha-com

Arena Pharmaceuticals 11/28/2011

10:44 : Arena Pharmaceuticals ([[ARNA]] +9.4%) pops after Piper Jaffray upgrades ... - Arena Pharmaceuticals (ARNA +9.4%) pops after Piper Jaffray upgrades it to Neutral ahead of its lorcaserin New Drug Application re-submission at year-end. Piper says the company has made substantial progress addressing the ...
Source : seekingalpha-com
actualidad Arena Pharmaceuticals -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts